ADAP
Price
$0.10
Change
-$0.00 (-0.00%)
Updated
Jul 29, 04:59 PM (EDT)
Capitalization
27.8M
7 days until earnings call
IKNA
Price
$17.16
Change
+$0.72 (+4.38%)
Updated
Jul 25 closing price
Capitalization
718.82M
8 days until earnings call
Interact to see
Advertisement

ADAP vs IKNA

Header iconADAP vs IKNA Comparison
Open Charts ADAP vs IKNABanner chart's image
Adaptimmune Therapeutics
Price$0.10
Change-$0.00 (-0.00%)
Volume$46.42K
Capitalization27.8M
Ikena Oncology
Price$17.16
Change+$0.72 (+4.38%)
Volume$38.11K
Capitalization718.82M
ADAP vs IKNA Comparison Chart in %
Loading...
ADAP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IKNA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ADAP vs. IKNA commentary
Jul 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ADAP is a Hold and IKNA is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 30, 2025
Stock price -- (ADAP: $0.10 vs. IKNA: $17.16)
Brand notoriety: ADAP and IKNA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ADAP: 1036% vs. IKNA: 185%
Market capitalization -- ADAP: $27.8M vs. IKNA: $718.82M
ADAP [@Biotechnology] is valued at $27.8M. IKNA’s [@Biotechnology] market capitalization is $718.82M. The market cap for tickers in the [@Biotechnology] industry ranges from $315.74B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ADAP’s FA Score shows that 0 FA rating(s) are green whileIKNA’s FA Score has 1 green FA rating(s).

  • ADAP’s FA Score: 0 green, 5 red.
  • IKNA’s FA Score: 1 green, 4 red.
According to our system of comparison, IKNA is a better buy in the long-term than ADAP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ADAP’s TA Score shows that 5 TA indicator(s) are bullish while IKNA’s TA Score has 3 bullish TA indicator(s).

  • ADAP’s TA Score: 5 bullish, 5 bearish.
  • IKNA’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, ADAP is a better buy in the short-term than IKNA.

Price Growth

ADAP (@Biotechnology) experienced а -61.59% price change this week, while IKNA (@Biotechnology) price change was +15.32% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.71%. For the same industry, the average monthly price growth was +15.03%, and the average quarterly price growth was +41.55%.

Reported Earning Dates

ADAP is expected to report earnings on Nov 05, 2025.

IKNA is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (+2.71% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IKNA($719M) has a higher market cap than ADAP($27.8M). IKNA YTD gains are higher at: -12.805 vs. ADAP (-80.527). IKNA has less debt than ADAP: IKNA (6.61M) vs ADAP (48.7M).
ADAPIKNAADAP / IKNA
Capitalization27.8M719M4%
EBITDA-50.18MN/A-
Gain YTD-80.527-12.805629%
P/E RatioN/AN/A-
Revenue180MN/A-
Total Cash59.6MN/A-
Total Debt48.7M6.61M737%
FUNDAMENTALS RATINGS
ADAP: Fundamental Ratings
ADAP
OUTLOOK RATING
1..100
1
VALUATION
overvalued / fair valued / undervalued
1..100
51
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
50
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ADAPIKNA
RSI
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
82%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
85%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
85%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
86%
Advances
ODDS (%)
Bullish Trend 5 days ago
78%
Bullish Trend 22 days ago
83%
Declines
ODDS (%)
Bearish Trend 8 days ago
90%
Bearish Trend 16 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
90%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
ADAP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IKNA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
STZ175.833.23
+1.87%
Constellation Brands
MSGS201.08-1.19
-0.59%
Madison Square Garden Sports Corp
FVCB13.00-0.15
-1.14%
FVCBankcorp
PERI10.90-0.30
-2.68%
Perion Network Ltd
SMSI0.71-0.07
-8.73%
Smith Micro Software

ADAP and

Correlation & Price change

A.I.dvisor indicates that over the last year, ADAP has been loosely correlated with CANF. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if ADAP jumps, then CANF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ADAP
1D Price
Change %
ADAP100%
+4.90%
CANF - ADAP
42%
Loosely correlated
+1.73%
AKBA - ADAP
41%
Loosely correlated
-2.37%
ORMP - ADAP
36%
Loosely correlated
-0.90%
AUTL - ADAP
33%
Poorly correlated
-3.78%
CSLLY - ADAP
32%
Poorly correlated
+1.05%
More

IKNA and

Correlation & Price change

A.I.dvisor indicates that over the last year, IKNA has been closely correlated with ADAP. These tickers have moved in lockstep 79% of the time. This A.I.-generated data suggests there is a high statistical probability that if IKNA jumps, then ADAP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IKNA
1D Price
Change %
IKNA100%
N/A
ADAP - IKNA
79%
Closely correlated
+4.90%
ABCZF - IKNA
72%
Closely correlated
N/A
ATRA - IKNA
72%
Closely correlated
+1.10%
CANF - IKNA
41%
Loosely correlated
+1.73%
VNDA - IKNA
37%
Loosely correlated
-0.43%
More